Financials
- Market Capitalization 8.25 B
- Employee 691
- Founded 2014
- CEO Rich Adcock
- Website www.immunitybio.com
- Headquarter Delaware, United States
- FIGI BBG007T9DYW9
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-5.21
売上高対価格比率
16.08
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 1010 | TGTX TG Therapeutics, Inc. - Common Stock | 54.89 USD | -0.22% | -4.72% | +9.47% | +43.35% | 8.40 B USD | ||
| 1017 | APGE Apogee Therapeutics, Inc. - Common Stock | 133.96 USD | +0.10% | +0.33% | +55.42% | +149.97% | 8.29 B USD | ||
| 1032 | PCVX Vaxcyte, Inc. - Common Stock | 56.21 USD | -1.44% | -6.33% | +13.40% | +32.88% | 8.12 B USD | ||
| 1039 | IMVT Immunovant, Inc. - Common Stock | 38.77 USD | +0.18% | -1.02% | +16.74% | +101.82% | 7.96 B USD |